Revvity (NYSE:RVTY) Updates FY 2026 Earnings Guidance

Key Points

• FY2026 guidance: Revvity set EPS guidance of $5.20–$5.30 and revenue guidance of $2.8 billion, both below consensus estimates (EPS $5.40; revenue $3.0 billion).
• Analyst response was mixed with several target‑price changes; the sell‑side consensus remains an average "Hold" rating and an average target of $109.36, while the stock trades near $86.79 (1‑year range $81.22–$118.30).
• Recent performance and payout: Revvity beat the quarter with $1.06 EPS (vs. $1.02 est.) and $711.1M revenue (vs. $704.2M est.), and declared a quarterly dividend of $0.07 ($0.28 annualized, ~0.3% yield).

Revvity (NYSE:RVTY - Get Free Report) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 5.200-5.300 for the period, compared to the consensus estimate of 5.400. The company issued revenue guidance of $2.8 billion-$2.8 billion, compared to the consensus revenue estimate of $3.0 billion.

Analysts Set New Price Targets

Several research firms recently commented on RVTY. Robert W. Baird cut their target price on shares of Revvity from $129.00 to $125.00 and set an "outperform" rating on the stock in a research report on Monday. Evercore raised their price objective on shares of Revvity from $112.00 to $118.00 and gave the stock an "outperform" rating in a research report on Tuesday, February 3rd. Wells Fargo & Company raised their price objective on shares of Revvity from $107.00 to $110.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 3rd. Barclays reiterated an "equal weight" rating and issued a $95.00 target price (down from $118.00) on shares of Revvity in a report on Tuesday, April 14th. Finally, Jefferies Financial Group increased their target price on Revvity from $100.00 to $105.00 and gave the stock a "hold" rating in a report on Monday, February 2nd. Three investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $109.36.

Revvity Stock Up 0.1%

RVTY stock opened at $86.79 on Tuesday. The company has a current ratio of 1.68, a quick ratio of 1.40 and a debt-to-equity ratio of 0.36. The company's 50 day moving average is $90.39 and its 200 day moving average is $96.82. The stock has a market cap of $9.70 billion, a price-to-earnings ratio of 41.73, a price-to-earnings-growth ratio of 1.85 and a beta of 1.05. Revvity has a 1-year low of $81.22 and a 1-year high of $118.30.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.04. Revvity had a return on equity of 7.92% and a net margin of 8.45%.The firm had revenue of $711.12 million during the quarter, compared to analyst estimates of $704.20 million. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Sell-side analysts predict that Revvity will post 5.39 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity's payout ratio is 13.46%.

Institutional Investors Weigh In On Revvity

Several hedge funds have recently added to or reduced their stakes in the company. Pacer Advisors Inc. increased its holdings in shares of Revvity by 4.7% in the fourth quarter. Pacer Advisors Inc. now owns 11,152 shares of the company's stock worth $1,079,000 after buying an additional 504 shares during the period. Virtu Financial LLC purchased a new stake in Revvity in the fourth quarter worth about $384,000. Corient Private Wealth LLC increased its stake in shares of Revvity by 985.8% during the fourth quarter. Corient Private Wealth LLC now owns 126,664 shares of the company's stock valued at $12,245,000 after purchasing an additional 114,999 shares in the last quarter. Alberta Investment Management Corp purchased a new stake in shares of Revvity during the fourth quarter valued at approximately $1,442,000. Finally, Mercer Global Advisors Inc. ADV lifted its position in Revvity by 10.4% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 15,656 shares of the company's stock valued at $1,515,000 after purchasing an additional 1,480 shares during the period. Institutional investors own 86.65% of the company's stock.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.